Scynexis Inc (US: SCYX) — Healthcare · Share Price, Chart & Market Data
About: SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.02 (-2.86%)
SCYXScynexis Inc
Loading watchlist status…
Trade SCYX now
Scynexis Inc share price
SCYX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:06 am GMT+0
SCYX price performance
-3.774%
5D
25.477%
1M
59.749%
YTD
4.874%
1Y
SCYX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:06 am GMT+0
SCYX details
SCYX Market Signals